Reactivation Tuberculosis in A/J
Reactivation Tuberculosis in A/J
批准号:
6930965
负责人:
Chinnaswamy Jagannath
金额:
$37.13万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2007-07-31
关键词:
Mycobacterium tuberculosiscellular immunitychemokinecomplement inhibitorscomplement pathwayenzyme linked immunosorbent assaygene deletion mutationimmunogeneticsinterleukin 1laboratory mouseleukocyte activation /transformationlung disordermacrophagenuclear factor kappa betapolymerase chain reactionrelapse /recurrencetumor necrosis factor alpha
中文摘要
描述(由申请人提供)
世界上有四分之一的人口感染了M。结核
导致每年约290万人死亡。再活化
结核病是当今成人结核病的主要原因,
导致再激活的机制是复杂和神秘的。以来
动物模型对于了解结核病的发病机制是有用的,我们
进行了一系列研究,以标准化急性,慢性
以及通过改变小鼠品系、途径和剂量,
感染我们发现A/J小鼠高度易感,而C57 B1/6小鼠高度易感,
当小鼠被感染时,
静脉注射或通过气雾剂途径。A/J小鼠不能在肺中形成肉芽肿
并且它们的巨噬细胞在杀死MTB方面有缺陷。与C57 B1/6小鼠不同,A/J
小鼠也经历了早期和几乎一致的结核病复发
遵循康奈尔模式。A/J小鼠在编码以下的基因中具有缺失:
补体C5,在完整的小鼠中产生C5 a过敏毒素,
巨噬细胞的细胞因子和趋化因子合成的调节剂。因此在
在这项研究中,我们将检验缺乏C5 a的假设,
损害了小鼠的免疫反应,
结核病的治疗方法有以下几种。具体目标我会调查
C5基因的缺失是否影响细胞因子(TNF α,
IL-1-β和IL-6),防止巨噬细胞活化,从而防止巨噬细胞
介导的A/J小鼠中MTB的杀伤。具体目标II将调查
C5基因缺失对结核分枝杆菌分泌趋化因子的影响
感染的A/J巨噬细胞,并评估它们是否在引起
免疫细胞流入肺部并形成肉芽肿。 具体
目的III将描述组织学,细胞因子和趋化因子的反应,
在A/J小鼠的肺中测定免疫应答的类型(Th 1对Th 2),
在结核病的复发过程中占主导地位。这些研究
预计将加强我们对假定机制的理解,
肺结核在小鼠肺中的重新激活,并最终帮助我们
制定更好的策略来预防人类结核病。
英文摘要
DESCRIPTION (provided by applicant)
One quarter of the world's population is infected with M. tuberculosis
resulting in approximately 2.9 million deaths each year. Reactivation
tuberculosis is the major cause of adult tuberculosis today although the
mechanisms that predispose to reactivation are complex and enigmatic. Since
animal models are useful for understanding pathogenesis of tuberculosis, we
performed a series of studies to standardize murine models of acute, chronic
and reactivation tuberculosis by varying the mouse strain, route and dose of
infection. We then found that A/J mice were highly susceptible while C57Bl/6
mice were relatively resistant to progressive disease when infected either
i.v. or via aerosol routes. A/J mice were unable to form granulomas in lungs
and their macrophages were defective in killing MTB. Unlike C57Bl/6 mice, A/J
mice also underwent an early and near uniform reactivation of tuberculosis
following the Cornell model. A/J mice have a deletion in the gene encoding for
Complement C5 which in intact mice yields the C5a anaphylatoxin, a known
regulator of cytokine and chemokine synthesis of macrophages. Therefore, in
this investigation, we will examine the hypothesis that the lack of C5a
compromises the immune responses in mice allowing the reactivation of
tuberculosis through the following aims. Specific Aim I will investigate
whether the deletion in C5 gene affects the synthesis of cytokines (TNF alpha,
IL1-beta and IL-6), prevents macrophage activation and thereby macrophage
mediated killing of MTB in A/J mice. Specific Aim II will investigate the
effects of the deletion in C5 gene to the secretion of chemokines by MTB
infected A/J macrophages and evaluate whether they are important in causing
influx of immune cells into the lungs and formation of granulomas. Specific
Aim III will characterize histological, cytokine and chemokine responses of
lungs in A/J mice to determine the type of immune response (Th1 vs Th2) that
dominates during the reactivation of tuberculosis. These studies are
anticipated to enhance our understanding on putative mechanisms that precede
the reactivation of tuberculosis in the lungs of mice and ultimately help us
to develop better strategies to prevent tuberculosis in man.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
补体 C5a 过敏毒素是小鼠树突状细胞诱导的针对牛分枝杆菌 BCG 感染的 Th1 免疫的先天决定因素。
DOI:
10.1189/jlb.0206119
发表时间:
2007
期刊:
Journal of leukocyte biology
影响因子:
5.5
作者:
[Moulton,RachelA, Mashruwala,MaryAnne, Smith,AmandaK, Lindsey,DevinR, Wetsel,RickA, Haviland,DavidL, Hunter,RobertL, Jagannath,Chinnaswamy]
通讯作者:
Jagannath,Chinnaswamy
Role of metabolic Me-macrophages in the pathogenesis of tuberculosis during diabetes
-
批准号:9893648
-
项目类别:
-
资助金额:$24.54万
-
财政年份:2020
-
负责人:Chinnaswamy Jagannath
-
依托单位:
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
-
批准号:10398248
-
项目类别:
-
资助金额:$86.73万
-
财政年份:2018
-
负责人:Chinnaswamy Jagannath
-
依托单位:
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
-
批准号:10162489
-
项目类别:
-
资助金额:$87.77万
-
财政年份:2018
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Mechanisms of Mycobacterial Antigen Processing
-
批准号:8302425
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2009
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Mechanisms of Mycobacterial Antigen Processing
-
批准号:7585073
-
项目类别:
-
资助金额:$46.35万
-
财政年份:2009
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Mechanisms of Mycobacterial Antigen Processing
-
批准号:8115175
-
项目类别:
-
资助金额:$43.41万
-
财政年份:2009
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Chracteristics of An M. Tuberculosis Derived Vaccine
-
批准号:7920690
-
项目类别:
-
资助金额:$12.88万
-
财政年份:2009
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Mechanisms of Mycobacterial Antigen Processing
-
批准号:8495214
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2009
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Mechanisms of Mycobacterial Antigen Processing
-
批准号:7879289
-
项目类别:
-
资助金额:$44.5万
-
财政年份:2009
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Characterization of an M. tuberculosis vaccine
-
批准号:6835662
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Characterization of an M. tuberculosis vaccine
-
批准号:6999730
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Chracteristics of An M. Tuberculosis Derived Vaccine
-
批准号:8101025
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Characterization of an M. tuberculosis vaccine
-
批准号:6621994
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Chracteristics of An M. Tuberculosis Derived Vaccine
-
批准号:7655374
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Chracteristics of An M. Tuberculosis Derived Vaccine
-
批准号:7883476
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Characterization of an M. tuberculosis vaccine
-
批准号:6687781
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Chracteristics of An M. Tuberculosis Derived Vaccine
-
批准号:7548961
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Characterization of an M. tuberculosis vaccine
-
批准号:6438079
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2002
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Reactivation Tuberculosis in A/J Mice
-
批准号:6412380
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2001
-
负责人:Chinnaswamy Jagannath
-
依托单位:
Reactivation Tuberculosis in A/J Mice
-
批准号:6615801
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2001
-
负责人:Chinnaswamy Jagannath
-
依托单位:
海外基金